Muhurat Trading 2026: Our Samvat 2083 Watchlist and the Risks Behind It

Muhurat Trading

11 stocks Anmol Finsec is studying this Diwali, with one reason and one risk for each

Nov 5, 2026

Muhurat trading 2026 is on Sunday, 8 November, from 2:20 to 3:30 pm

NSE and BSE will hold the one-hour Muhurat trading session on Sunday, 8 November 2026, from 2:20 pm to 3:30 pm, with the pre-open at 2:05 pm. A new Samvat, 2083, begins with it.

I started my career in 1995, and Anmol Finsec has been in these markets since 1998. In that time the Muhurat hour has not changed much. What changes is the year around it.

Live update (08 Nov, 03:55 AM):

The numbers show the gap. Between 2006 and 2025, the Nifty moved less than 1% from the previous close in 19 of 20 Muhurat sessions. The exception was 2008, when it rose 6.35% (Finnovate, Business Standard). But from one Muhurat close to the next, the Nifty ended higher in 15 of 19 years, and the outcomes ranged from a fall of about 53% to a gain of about 92% (price returns, excluding dividends).

The hour is small. The year is where both the risk and the return sit.

What Anmol Ratna 2083 is, and what it is not

Anmol Ratna 2083 is our Samvat 2083 research watchlist: 11 stocks our team is studying, each with a reason and a risk written side by side. It is a starting point for your own homework.

It is not a set of buy calls. It carries no target prices and no promise of returns, and this article leaves prices out on purpose.

Two facts to keep in mind. Ten of the 11 stocks trade below their 52-week highs after a difficult Samvat 2082; Corona Remedies sits at its high. And all 11 are small or micro caps, which can fall faster than the index and stay down longer.

The 11 names, with the reason and the risk

Read the last column first.

Stock

Sector

What it does

Why we are studying it

The risk

MobiKwik

Fintech

Digital wallet, UPI payments and consumer lending app

Digital lending and payments operating leverage

Still loss-making; very volatile

Anupam Rasayan

Specialty chemicals

Custom-made specialty chemicals for global agro and pharma

China+1 custom-synthesis tailwind

P/E about 75; 32.9% of promoter stake pledged

Rubicon Research

Pharma

R&D-led specialty generic medicines, mainly for the US

US specialty generics pipeline scaling

Up about 185% from its 52-week low; near its high

Thyrocare

Healthcare

Pan-India pathology labs with a centralised, low-cost model

Rising demand for preventive health tests

Competitive pricing pressure in diagnostics

Krishna Defence

Defence

Naval-grade steel, fabrication and defence consumables supplier

Indigenous naval shipbuilding push

Micro-cap; lumpy order inflows

Corona Remedies

Pharma

Branded medicines in women’s health, cardio and pain

Branded domestic pharma, steady compounding

At its 52-week high, above the analyst average target

Pine Labs

Fintech

Merchant POS payments, gift cards and issuing tech

Merchant digital-payments rails at scale

One brokerage initiated coverage at REDUCE; weak momentum

Molbio Diagnostics

Healthcare

Truenat point-of-care molecular (PCR) testing devices

Point-of-care molecular testing goes mainstream

Fresh IPO (listed August 2026); lock-in expiries ahead

Avalon Technologies

Electronics manufacturing

Electronics manufacturing services for global industrial OEMs

Make-in-India electronics manufacturing upcycle

P/E about 102; Q2 results due 12 November 2026

SKF India

Auto and industrial

Bearings and related solutions for vehicles and industry

Near its 52-week low, more focused after the demerger

Demerger muddies historical comparisons

CAMS

Capital markets

India’s largest mutual-fund registrar and transfer agent

SIP flows feed a duopoly business

Fee yields sensitive to SEBI TER changes

Source: Anmol Finsec research note, Diwali Muhurat Trading 2026 (data as of 4-5 November 2026).

How to read a watchlist like this

A list tells you what to study. It does not tell you what to own, or how much. Four questions help.

  1. What is this money for, and when do I need it? A small or micro cap can stay below an earlier price for years. Money you need soon does not belong in a stock that can do that.
  2. How far can I see it fall on paper without changing my plan? As of 4-5 November, Pine Labs trades about 44% below its 52-week high and SKF India about 37% below. That is what a fall in this part of the market looks like.
  3. Do I understand the risk as well as the story? Every name above has a good story. Most investors can recite it. Fewer can recite the risk.
  4. Am I deciding on one hour, or on a plan? Muhurat is a good day to start a habit. It is not a reason to rush a decision.

How much of any of these belongs in a portfolio depends on your goals, your age and everything else you own. That is a conversation for you and a SEBI-registered adviser.

One question for you

When you build a Diwali watchlist, what do you check first: the story, the valuation or the risk? I would like to hear your answer in the comments.

Wishing you and your family a happy Diwali and a prosperous Samvat 2083.

For information only, not investment advice. This is a research watchlist, not a recommendation to buy or sell any security. Facts as of 4-5 November 2026 unless stated. [SEBI research analyst registration number and holding disclosure to be added after compliance review.]

Sources

  • Anmol Finsec research note, Diwali Muhurat Trading 2026, Samvat 2083 (company data from NSE via Kotak Neo, Upstox, INDmoney, Sharpely, StockAnalysis and Business Standard, 4-5 November 2026)
  • Muhurat 2026 timing: Angel One and InCred Money
  • Nifty Muhurat closing levels, 2006 to 2025: Finnovate
  • Muhurat 2008 session: Business Standard

Disclaimer: This article is for educational purposes only and is not a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks. Please read all offer documents carefully and consult your financial advisor before investing.

Leave a Reply

Your email address will not be published. Required fields are marked *